Money, Fiance News, Press Release Distribution
Financial News and Press Release Distribution Services

Submit RSS Feed | About US | Contact Us





Home | Personal Finance News | Submit Press Release
Unlimited Press Release Distribution
Press release distribution service

Money News Media
Bankrate
CNBC
CNNMoney
Finacial Times
FOX Business
Moneynews


Money News Now


USNews
Reuters Money
RSS News Feed
Get your news feed listed here as other news media shown above! Submit RSS News Feed

Personal Finance News Releases

Global Report on Immuron Limited - Product Pipeline Review – 2015, Market Analysis, Review, Trend, Forecast 2015-25

 



(MoneyNewsWire.Net, December 11, 2015 ) This report provides comprehensive information on the current therapeutic developmental pipeline of Immuron Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.



To Browse a Full Report with TOC @ http://www.researchmoz.us/immuron-limited-product-pipeline-review-2015-report.html



Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.



The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.



To Download Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=486232



Scope



- The report provides brief overview of Immuron Limited including business description, key information and facts, and its locations and subsidiaries

- The report reviews current pipeline of Immuron Limiteds human therapeutic division and enlists all their major and minor projects

- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones

- Special feature on out-licensed and partnered product portfolio

- The report summarizes all the dormant and discontinued pipeline projects

- Latest company statement

- Latest news and deals relating to the Immuron Limiteds pipeline products



Reasons to buy



- Evaluate Immuron Limiteds strategic position with total access to detailed information on its product pipeline

- Assess the growth potential of Immuron Limited in its therapy areas of focus

- Identify new drug targets and therapeutic classes in the Immuron Limiteds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

- Develop strategic initiatives by understanding the focus areas of Immuron Limited and exploit collaboration and partnership opportunities

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage



To Enquire Regarding This Report @ http://www.researchmoz.us/enquiry.php?type=E&repid=486232



For More Reports Click Here @ http://www.prweb.com/search.aspx?search-releases=researchmoz&hitsPerPage=20



For More Information Kindly Contact:



ResearchMoz

Mr. Nachiket Ghumare,

Email: sales@researchmoz.us

Website: http://www.researchmoz.us/

Tel: 866-997-4948 (Us-Canada Toll Free)

Tel: +1-518-621-2074

Researchmoz Global Pvt.Ltd

Researchmoz, Mr. Nachiket Ghumare

+1-518-621-2074

sales@researchmoz.us

Source: EmailWire.Com


Personal Finance News
  • Auto
  • CDs
  • College
  • Credit Cards
  • Insurance
  • Mortgage
  • Mutual Funds
  • Retirement
  • Savings
  • Taxes

  • Money RSS Marketpalce

    Free Finance Magazines Downloads
    Get free publications including magazines, white papers on finance, investments.
    Submit RSS news feed on Finance, Investment.
    Have your feed on news, products or services displayed under this marketpalce. The feed also displayed on a full page and updated daily.



    Money NewsWire is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

    For unlimited press release distribution for $99 per month or $999 per year, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
    Copyright 2009 GroupWeb Media LLC

    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    Money-NewsWire.Net - Newswire and Press Release service of GroupWeb Media LLC